AD-driven MCI aAB biomarkers are capable of identifying preclinical AD pathology in otherwise cognitively normal (CDR = 0) STRIDE patients.
收藏数据链接：
官方服务：
资源简介：
AD-driven MCI aAB biomarkers are capable of identifying preclinical AD pathology in otherwise cognitively normal (CDR = 0) STRIDE patients.
创建时间：
2019-11-15
